Stockbroker tips from ShareCast

HSBC trims Lloyds target price and upgrades RBS, but prefers Barclays

Fri 17 August 2018 14:41

(Sharecast News) - Analysts at HSBC sounded a more positive note on RBS and Barclays on Friday, but not Lloyds, following the 15-20% decline in their share prices over the past three months, on the back of concerns around geopolitics (and Brexit).

Friday broker round-up

Fri 17 August 2018 14:22

(Sharecast News) - esure: Barclays upgrades to equal weight with a target price of 280p.

Broker tips: KAZ Minerals, RBS, Barclays, Lloyds, Glencore

Fri 17 August 2018 13:47

(Sharecast News) - KAZ Minerals was downgraded to 'neutral' by analysts at Credit Suisse on Friday, while UBS slashed its share price target.

KAZ Minerals sinks as analysts fret about Baimskaya risks

Fri 17 August 2018 10:09

(Sharecast News) - KAZ Minerals was downgraded to 'neutral' by analysts at Credit Suisse on Friday, while UBS slashed its share price target.

Buy platinum metal rather than the miners, says ShoreCap

Fri 17 August 2018 08:08

(Sharecast News) - Prospects of industrial action in South Africa could make speculation in platinum worthwhile, suggested stockbroker Shore Capital on Friday.

Peel Hunt upgrades Hikma, says upgrade cycle will drive shares

Thu 16 August 2018 14:17

(Sharecast News) - Peel Hunt upgraded Hikma Pharmaceuticals to 'add' from 'hold' on Thursday and bumped up the price target to 1,950p from 1,160p following the company's "strong" first-half results a day earlier.

Thursday broker round-up

Thu 16 August 2018 13:09

(Sharecast News) - Esure Group: UBS upgrades to neutral with a target price of 280p.

Morgan Stanley downgrades Informa but still sees attractions

Thu 16 August 2018 12:36

(Sharecast News) - Morgan Stanley downgraded Informa after its results did not impress last month, though there was still lots to like about the exhibitions organiser and business publisher.

Broker tips: Hikma Pharmaceuticals, eSure, Informa, Huntsworth

Thu 16 August 2018 12:35

(Sharecast News) - Peel Hunt upgraded Hikma Pharmaceuticals to 'add' from 'hold' on Thursday and bumped up the price target to 1,950p from 1,160p following the company's "strong" first-half results a day earlier.

UBS upgrades Esure to 'neutral' after Bain deal

Thu 16 August 2018 12:28

(Sharecast News) - UBS upgraded Esure to 'neutral' from 'sell' and hiked the price target to 280p after the insurer agreed to be bought by private equity firm Bain Capital for 280p a share, as it said there is a high probability of deal success.